Brain penetrable histone deacetylase 6 inhibitor SW-100 ameliorates memory and learning impairments in a mouse model of fragile X syndrome

AP Kozikowski, S Shen, M Pardo… - ACS chemical …, 2018 - ACS Publications
Disease-modifying therapies are needed for Fragile X Syndrome (FXS), as at present there
are no effective treatments or cures. Herein, we report on a tetrahydroquinoline-based …

[HTML][HTML] Ubiquitin in influenza virus entry and innate immunity

A Rudnicka, Y Yamauchi - Viruses, 2016 - mdpi.com
Viruses are obligatory cellular parasites. Their mission is to enter a host cell, to transfer the
viral genome, and to replicate progeny whilst diverting cellular immunity. The role of …

Odd-chain fatty acids as novel histone deacetylase 6 (HDAC6) inhibitors

MK Ediriweera, NB To, Y Lim, SK Cho - Biochimie, 2021 - Elsevier
The dysregulation of histone deacetylases (HDACs) is closely associated with
tumorigenesis and has emerged as a promising target for anti-cancer drugs. Some odd …

Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors

MT Tavares, AP Kozikowski, S Shen - European journal of medicinal …, 2021 - Elsevier
Abstract Histone deacetylase 6 (HDAC6) is a zinc-dependent HDAC that mainly modulates
the acetylation status of non-histone substrates, such as α-tubulin and heat shock protein 90 …

Marbostat-100 defines a new class of potent and selective antiinflammatory and antirheumatic histone deacetylase 6 inhibitors

A Sellmer, H Stangl, M Beyer… - Journal of medicinal …, 2018 - ACS Publications
Epigenetic modifiers of the histone deacetylase (HDAC) family contribute to autoimmunity,
cancer, HIV infection, inflammation, and neurodegeneration. Hence, histone deacetylase …

[HTML][HTML] Microtubules in influenza virus entry and egress

C Simpson, Y Yamauchi - Viruses, 2020 - mdpi.com
Influenza viruses are respiratory pathogens that represent a significant threat to public
health, despite the large-scale implementation of vaccination programs. It is necessary to …

Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: Structure, function and design

J Peng, F Xie, P Qin, Y Liu, H Niu, J Sun, H Xue… - Bioorganic …, 2023 - Elsevier
HDAC6, a member of the histone deacetylase family, mainly is a cytosolic protein and
regulates cell growth by acting on non-histone substrates, such as α-tubulin, cortactin, heat …

[HTML][HTML] HDAC6 inhibition alleviates ischemia-and cisplatin-induced acute kidney injury by promoting autophagy

L Shi, Z Song, C Li, F Deng, Y Xia, J Huang, X Wu… - Cells, 2022 - mdpi.com
Histone deacetylase (HDAC) 6 exists exclusively in cytoplasm and deacetylates cytoplasmic
proteins such as α-tubulin. HDAC6 dysfunction is associated with several pathological …

Exploring structural determinants of inhibitor affinity and selectivity in complexes with histone deacetylase 6

JD Osko, NJ Porter, PA Narayana Reddy… - Journal of medicinal …, 2019 - ACS Publications
Inhibition of histone deacetylase 6 (HDAC6) has emerged as a promising therapeutic
strategy for the treatment of cancer, chemotherapy-induced peripheral neuropathy, and …

Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the …

O Rabal, JA Sánchez-Arias… - European journal of …, 2018 - Elsevier
We have identified chemical probes that act as dual phosphodiesterase 5 (PDE5) and
histone deacetylase 6 (HDAC6)-selective inhibitors (> 1 log unit difference versus class I …